NCT01211405 - Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 10, 2010

Primary Completion Date

June 4, 2015

Study Completion Date

August 2, 2016

Conditions

Posttraumatic Stress Disorder

Interventions

DRUG

Low dose MDMA-assisted therapy

30 mg midomafetamine HCl administered p.o. once at start of an experimental session. Upon mutual agreement, this may be followed by a supplemental dose of 15 mg 1.5 to 2 hours later

DRUG

Medium dose MDMA-assisted therapy

75 mg midomafetamine HCl administered p.o. once at start of an experimental session. Upon mutual agreement, this may be followed by a supplemental dose of 37.5 mg 1.5 to 2 hours later

DRUG

Full dose MDMA-assisted therapy

125 mg midomafetamine HCl administered p.o. once at start of an experimental session. Upon mutual agreement, this may be followed by a supplemental dose of 62.5 mg 1.5 to 2 hours later

BEHAVIORAL

Therapy

Non-directive therapy during each session

Trial Locations (1)

29464-4345

Offices of Michael Mithoefer, Mt. Pleasant